分享 收藏

Recombinant Human TARC/CCL17 Protein

品牌：翌圣生物
產地：
供應商報價：面議

翌圣生物科技(上海)股份有限公司更新時間：2024-12-24 09:03:45

銷售范圍售全國

入駐年限第1年

營業執照已審核

同類產品趨化因子(83件)

立即掃碼咨詢

聯系方式：400-611-1883

聯系我們時請說明在儀器網（m.ghhbs.com.cn）上看到的!

掃碼分享

為您推薦

Recombinant Human Eotaxin-3/CCL266 重組人Eotaxin-3/CCL26

Recombinant Human Exodus-2/CCL21重組人 Exodus-2/CCL21
Recombinant Human I-309/CCL1重組人 I-309/CCL1

Recombinant Human LD78β/CCL3L1 重組人LD78β/CCL3L1
Recombinant Human MIP-1α/CCL3重組人MIP-1α/CCL3

Recombinant Human MCP-1/CCL2 重組人MCP-1/CCL2

詳細介紹

CCL17, also known as thymus and activation-related chemokine (TARC), a small cytokine belonging to the C-C chemokine family. Among CC chemokine family members, CCL17 has approximately 24 - 29% amino acid sequence identity with RANTES, MIP-1 alpha, MIP-1 beta, MCP-1, MCP-2, MCP-3 and I-309. CCL17 is constitutively expressed in thymus, and at a lower level in lung, colon, and small intestine. CCL17 is also transiently expressed in phytohemagglutinin-stimulated peripheral blood mononuclear cells. CCL17 has been shown to be chemotactic for T cell lines but not monocytes or neutrophils. CCL17 was identified to be a specific functional ligand for CCR4, a receptor that is selectively expressed on T cells.

Product Properties

Synonyms	MGC138273, SCYA17, SCYA17MGC138271
Accession	Q92583
GeneID	6361
Source	E.coli-derived Human TARC/CCL17, Ala24-Ser93.
Molecular Weight	Approximately 8.1 kDa.
AA Sequence	ARGTNVGREC CLEYFKGAIP LRKLKTWYQT SEDCSRDAIV FVTVQGRAIC SDPNNKRVKN AVKYLQSLER S
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	> 97% by SDS-PAGE and HPLC analyses.
Biological Activity	The biological activity determined by a chemotaxis bioassay using human T-lymphocytes is in a concentration range of 1.0-10 ng/mL. Fully biologically active when compared to standard.
Endotoxin	< 1.0 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 7.4, 150 mM NaCl.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.